Replies to post #157756 on Avid Bioservices Inc (CDMO)

[stoneroad]

Immunotherapy will be the theme in biotech for 2014 and there will be a plethora of opportunities for Peregrine to be in the limelight.

[north40000]

Roughly 5' discussion on CNBC. MRK, BMY, Yervoy, Nivo main discussion, no mention of PPHM that I heard by Morgan[do I recall her name?] or Leerink rep.

Same is true of earlier CNBC segment by Morgan that mentioned a few smaller biotechs, including CLDX and ATHX.

PSTI and INO continue stronger than most.